Domainex is the swiftly expanding contract research organization for pharmaceutical, biotech, academic, and patient foundations worldwide. Established in 2001, Domainex has grown its drug discovery service business and broadened its client base internationally, catering to UCB, FORMA Therapeutics, St George's University, and The Institute of Cancer Research. With a strong track record, Domainex has successfully delivered an average of one candidate drug annually, showcasing expertise and dedication to high-quality services.